| n (%) |
---|---|
Sex | |
 Male | 13 (56.52) |
 Female | 10 (43.48) |
Age, median (range) | 63 (31-80) |
BMI (kg/m2), median (range) | 23.7 (18-32) |
ASA | Â |
 ASA score 1 | 1 (4.35) |
 ASA score 2 | 19 (82.61) |
 ASA score 3 | 3 (13.04) |
Distance to anal verge (mm), median (range) | 54 (20-80) |
Tumor size (mm), median (range) | 20 (6-85) |
AJCC clinical stages | |
 Stage II | 8 (34.78) |
 Stage III | 15 (65.22) |
Clinical T stage | |
 cT2 | 2 (8.70) |
 cT3 | 21 (91.30) |
Clinical N stage | |
 cN0 | 8 (34.78) |
 cN1 | 11 (47.83) |
 cN2 | 4 (17.39) |
Neoadjuvant CCRT | 23 (100.00) |